Immediate Impact
38 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
2024 Standout
Works of Haya Al‐Saud being referenced
Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3)
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Haya Al‐Saud | 90 | 19 | 12 | 99 | 45 | 11 | 195 | |
| Ana Vega | 139 | 6 | 12 | 103 | 27 | 12 | 266 | |
| Clemens Freiberg | 132 | 4 | 16 | 107 | 61 | 15 | 260 | |
| Hye‐Young Nam | 77 | 3 | 13 | 80 | 81 | 11 | 215 | |
| Michelle E. Leonard | 152 | 9 | 13 | 95 | 28 | 10 | 256 | |
| Pietro De Togni | 97 | 12 | 21 | 46 | 16 | 10 | 256 | |
| Naeimeh Tayebi | 86 | 4 | 20 | 88 | 45 | 9 | 195 | |
| Zhuoying Yang | 178 | 14 | 18 | 44 | 54 | 14 | 284 | |
| Fiona Norris | 152 | 10 | 38 | 60 | 29 | 11 | 277 | |
| Xiangjie Xu | 184 | 6 | 19 | 48 | 29 | 13 | 266 | |
| Ewa Goljan | 88 | 3 | 18 | 76 | 39 | 9 | 204 |
All Works
Loading papers...